-

Veradigm Advances Deeper Clinical Insights Through NLP-Enhanced EHR Data

NLP-enhanced data from over 154 million patient records facilitates innovation in real-world evidence research via the Veradigm Network

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today the complete integration of advanced natural language processing (NLP) into its electronic health record (EHR) dataset. This integration enhances access to valuable insights from unstructured EHR data and combines it with structured data to create regulatory-grade, real-world data (RWD) that’s purpose-built for research.

This integration enhances access to valuable insights from unstructured EHR data and combines it with structured data to create regulatory-grade, real-world data that’s purpose-built for research.

Share

Veradigm Network EHR Data is sourced from over 154 million unique patient records and is one of the most comprehensive ambulatory databases in the United States, providing insights on a wide range of geographically and demographically diverse patients. Veradigm ensures that its NLP-enriched EHR data is standardized, de-identified, and designed to maximize research potential.

The dataset encompasses over five billion distinct patient notes sourced from multiple EHR systems and a diverse range of specialties, collected over a rolling five-year period. The unstructured data is then processed by Veradigm’s NLP models, developed by clinicians and data scientists to extract crucial clinical insights into structured data tables. Veradigm Network EHR Data seamlessly integrates with third-party datasets, offering researchers the flexibility to link and expand their analyses.

“The future of healthcare research relies on access to real-time, comprehensive data, and a significant portion of this data is unstructured,” said Stuart Green, SVP and General Manager at Veradigm. “Veradigm has invested in developing solutions that bring together disparate structured and unstructured data to provide researchers a more comprehensive understanding of the patient journey.”

These data offer valuable insights into therapy decisions, disease progression, and patient outcomes. Researchers can also leverage Veradigm’s data to support clinical trials, regulatory submissions, and safety studies.

Veradigm offers customized, high-quality data solutions to meet specific research and business needs. To learn more, contact a Veradigm representative at https://veradigm.com/contact.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions for the healthcare provider, payer, and biopharma markets. For more information about how Veradigm is fulfilling its mission of Transforming Health, Insightfully, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, Instagram, and YouTube.

© 2024 Veradigm LLC and/or its affiliates. All rights reserved. Cited marks are the property of Veradigm LLC and/or its affiliates. All other product or company names are the property of their respective holders, all rights reserved.

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@veradigm.com

Media:
Stephanie Bevan
336-406-3924
stephanie.bevan@veradigm.com

Veradigm

OTC Pink:MDRX

Release Versions

Contacts

Investors:
Jenny Gelinas
312-506-1237
Jenny.Gelinas@veradigm.com

Media:
Stephanie Bevan
336-406-3924
stephanie.bevan@veradigm.com

More News From Veradigm

Veradigm Extends Stockholder Rights Plan

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”) has approved an amendment to extend the Company’s existing Stockholder Rights Plan to December 31, 2026 (the “Rights Plan”). The Board's decision to extend the Rights Plan is based on its determination that many of the underlying risks and conditions that existed upon the initial adoption of the Right...

Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices

CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application for Veradigm Revenue Cycle Services (RCS) clients, designed to deliver faster, deeper revenue cycle insights and strengthen the value of ongoing performance reviews for independent practices. Independent practices continue to face rising administrative complexity and financial pressure, driven by den...

Veradigm and Meperia Launch Industry-First 8-Way Match EDI Platform to Strengthen Healthcare Supply Chain Integrity

CHICAGO & VERO BEACH, Fla.--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data, technology, and enterprise resource planning (ERP) solutions, and Meperia (now part of Genesis Automation Healthcare), a healthcare supply chain technology company specializing in AI-powered content and spend management solutions, announced today a strategic collaboration to launch a next-generation Electronic Data Interchange (EDI) solution, purpose-built for healthcare. This new EDI...
Back to Newsroom